GNH USA

Europe — EMA

Palexia Sr (Tapentadol Hydrochloride)

Tapentadol, the active ingredient in Palexia Sr, is an opioid analgesic presented as a unknown strength/tablet for oral use. It is indicated for the management of moderate to severe acute pain in adult patients.

International sale not permitted. Listed for the domestic market and B2B only.

Request sourcing

1
Pack/s

What is Tapentadol Hydrochloride?

Tapentadol, the active ingredient in Palexia Sr, is an opioid analgesic presented as a unknown strength/tablet for oral use. It is indicated for the management of moderate to severe acute pain in adult patients.

GNH USA supplies Palexia Sr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Tapentadol Hydrochloride used for?

Tapentadol is an opioid analgesic that acts on the central nervous system. - Acute postoperative pain: Provides relief of pain following surgical procedures. - Chronic musculoskeletal pain: Helps to manage the long‑term pain of conditions such as low back or osteoarthritis. - Cancer‑related pain: t      

What are the side effects of Tapentadol Hydrochloride?

Intro  

Common   -  

What precautions apply to Tapentadol Hydrochloride?

Intro  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Tapentadol Hydrochloride
Route
Oral Use
Manufacturer
Grünenthal Pharma Ltd.
Origin
EU

Related products